Discovery

There are two primary reasons cancer has not been cured yet:
1. Current treatments also kill normal cells which results in pain, suffering and often death by the patient.
2. The cancer cells mutate and the treatment becomes no longer effective.

This new method offers a solution to both of these challenges.
When these unique surface antigens are targeted, normal cells are not killed. And, if cancer cells mutate, the technique can be utilized to find new targets that exist on the newly mutated cancer cells.

Cancer is clearly the deadliest disease in the developed world. In the U.S., one in three women and one in two men will develop cancer in their lifetime. Not one age group or demographic escapes the devastating diagnosis of cancer. It’s the second leading cause of death in the U.S. and around the world with an estimated 9.5 million people dying of the disease each year.

These shocking statistics clearly show that existing therapies are not effective enough and new methods are desperately needed.

All cells, including cancer cells, have areas that can bind antibodies, called antigens. If unique cancer specific surface antigens are found, they can be targeted to kill cancer cells and not normal cells. Cancer Antibodies’ method can identify multiple unique cancer-specific surface antigens that exist only on cancer cells. Therapeutic antibodies can be developed to target these unique sites. The method is applicable across different types of cancer.